Daniel Birnbaum

Mutational landscape of inflammatory breast cancer

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT

Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer

Genomic characterization of metastatic breast cancers

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing

A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability

The ExAC browser: displaying reference data information from over 60 000 exomes

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study

Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

Prognostic and predictive value of PDL1 expression in breast cancer

Genomic profiling of inflammatory breast cancer: A review

Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes